Agilent TapeStation 4150 Automated Electrophoresis System
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institutes of Health (NIH) plans to award a non-competitive contract for the acquisition of an Agilent TapeStation 4150 Automated Electrophoresis System, designated under NAICS code 334516, with a threshold not exceeding $350,000. This presolicitation notice indicates an intent to issue the contract without full and open competition, specifically to Agilent Technologies, Inc. The acquisition is conducted under the Simplified Acquisition Procedures outlined in FAR Part 13, utilizing statutory authority that exempts the contract from competitive requirements. The contract will be governed by the latest applicable provisions effective as of March 2026. The system will support research conducted by the National Human Genome Research Institute’s Comparative Genomics Branch, which uses canine models to study genomic influences on various diseases relevant to human health. The equipment sought must meet operational needs emphasizing high throughput without advanced robotics. Although this is not a solicitation for competitive proposals, interested parties may submit capability statements and proposals by June 22, 2026, to demonstrate their qualifications. Responses must include technical and cost proposals, registration details, and be submitted electronically to the identified contracting officer. The government will decide whether to proceed on a sole-source basis or consider competitive options based on the responses received.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
General Information
Document Type:
Presolicitation
Synopsis Number:
75N98026Q00588
Posted Date:
June 10, 2026
Original Response Date:
June 22, 2026
Current Response Date:
June 22, 2026
Set Aside:
N/A
NAICS Code:
334516
Contracting Office Address
National Institutes of Health (NIH), Office of the Director (OD)
Office of Logistics and Operations (OLAO)
Office of Acquisition and Logistics Management (OALM)
Hospital and Laboratory Support Division
6701 Rockledge Drive
Bethesda, MD 20817
Description
INTRODUCTION
THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to:
Agilent Technologies, Inc.
2850 Centerville Rd
Wilmington DE 19808
NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE
The intended procurement is classified under NAICS code 334516 with a Size Standard $1000.
REGULATORY AUTHORITY
The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000).
STATUTORY AUTHORITY
This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
GENERAL INFORMATION
- Title: Agilent TapeStation 4150 Automated Electrophoresis System
- Background Information: The National Human Genome Research Institute (NHGRI) performs research expanding our knowledge of disease and its prevention, detection, diagnosis and treatment by investigating genomes and their interactions within the cell. The Comparative Genomics Branch (CGS) of the Cancer Genetics and Comparative Genomics Branch (CGCGB) of NHGRI conducts research using a combination of basic and translational science using canines as a model system for humans. CGS collaborate with Federal, academic researchers, and the public at large to obtain unique or disease-affected samples to study how diseases that occur in the genomes of canines translate to humans for example invasive Urinary Cancer, cleft palate abnormalities, to behavior patterns. The majority of CGS research activities requires instrumentation that possesses the ability to be high throughput whilst not requiring the use of advanced robotics machinery.
CLOSING STATEMENT
This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.
All responses must be received by June 22, 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98026Q00588. Responses may be submitted electronically to Mr. James Law, Contracting Officer at James.Law@nih.gov. Fax responses will not be accepted.
"All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.”